In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil
RSC Pharmaceutics · 2026 · 3 (3) · 738-748
DOI: 10.1039/d5pm00390c ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Debatrayee Dasgupta und 3 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Engineering Research Board.
Abstract (Originalsprache)
This work describes a biotin-targeted mesoporous silica nanocarrier that enables sequential and stimuli-responsive co-delivery of camptothecin as well as 5-fluorouracil for enhanced tumour suppression with reduced hepatic toxicity.
Förderung
- Science and Engineering Research Board
Zitieren
APA
Dasgupta, D., Thakore, S., Patel, A., & Seshadri, S. (2026). In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil. RSC Pharmaceutics, 3(3), 738-748. https://doi.org/10.1039/d5pm00390c
Vancouver
Dasgupta D, Thakore S, Patel A, Seshadri S. In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil. RSC Pharmaceutics. 2026;3(3):738-748. doi:10.1039/d5pm00390c
BibTeX
@article{Dasgupta2026,
author = {Dasgupta, Debatrayee and Thakore, Sonal and Patel, Anjali and Seshadri, Sriram},
title = {In vivo translation of a dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles for the co-delivery of camptothecin and 5-fluorouracil},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {3},
pages = {738--748},
doi = {10.1039/d5pm00390c}
}
EUVIMED